The DRAIN-HF study will evaluate the Aortix percutaneous mechanical circulatory support (pMCS) technology in patients with acute decompensated heart failure (ADHF) who are unresponsive to standard medical therapy.
December 08, 2023
Procyrion Announces First Patient Enrollments in the DRAIN-HF Pivotal IDE Trial for Aortix Percutaneous Mechanical Circulatory Support Technology
December 8, 2023 — Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac…
Read More
Dushani Ranasinghe, PhD, left, and Margaret Schwarz, MD, at Ranasinghe's graduation ceremony from the University of Notre Dame.
December 07, 2023
New Target Identified for Pulmonary Hypertension Treatment
December 7, 2023 — Indiana University School of Medicine researchers at the school’s South Bend regional campus, in…
Read More
The U.S. Food and Drug Administration (FDA) announced Cordis US Corp is recalling its INFINITI Angiographic Catheter due to products being shipped without undergoing sterilization procedures
December 07, 2023
Cordis US Corp Recalls INFINITI Angiographic Catheter due to Products Being Shipped Without Undergoing Sterilization Procedures
December 7, 2023 — The U.S. Food and Drug Administration (FDA) announced Cordis US Corp is recalling its INFINITI…
Read More
Cortex's fully integrated solution will include advanced diagnostic and therapeutic pulsed field ablation catheters supported by innovative mapping technology.
December 07, 2023
Ajax Health Establishes Cortex, a Comprehensive AFib Ablation Technology Company, with $90 Million Investment Led by KKR and Hellman and Friedman
December 7, 2023 — Ajax Health announced today the formation and funding of Cortex, a medical technology company…
Read More
The American Medical Association (AMA) released new principles for augmented intelligence (AI) development, deployment, and use – a critical step toward fostering a consistent governance structure for advancements in health care technology.
December 06, 2023
AMA Issues New Principles for AI Development, Deployment, and Use
December 6, 2023 — The American Medical Association (AMA) released new principles for augmented intelligence (AI)…
Read More
Raymond Benza, MD, Chief of Pulmonary Hypertension for the Mount Sinai Health System
December 05, 2023
Raymond Benza, MD, Heart Failure Expert, Named Chief of Pulmonary Hypertension for the Mount Sinai Health System
December 5, 2023 — Raymond Benza, MD, FACC, FAHA, FACP, a top expert in cardiovascular medicine and advanced heart…
Read More
David Epstein, MD
December 05, 2023
Cedars-Sinai Guerin Children’s Selects Pediatric Intensivist to Direct Congenital Cardiac Critical Care
December 5, 2023 — David Epstein, MD, a pediatrician who has dedicated his career to caring for very ill children, has…
Read More
As coronary computed tomography angiography (CCTA) progresses towards becoming the primary imaging modality for not only diagnostic purposes, but also for clinical trial endpoints, there is a need to address the requirements for generating high-quality CCTA image data to ensure accurate and robust CAD assessments
By Andrew Michalski, PhD and Rohit Sood MD, PhD
December 05, 2023
From the Clinic to Pharmaceutical Clinical Trials: Considerations for using Coronary CT Angiography (CCTA) in Atherosclerotic Cardiovascular Disease (ASCVD) Clinical Trials
Coronary artery disease (CAD), also known as ischemic heart disease, is the most common heart disease with a prevalence…
Read More
Take a look at the news making top headlines during the month of November on dicardiology.com
By Melinda Taschetta-Millane
December 05, 2023
DAIC's Top 10 for November
November was a busy month with many FDA approvals and breaking clinical trial results. Take a look at the news making…
Read More
December 04, 2023
Minneapolis Heart Institute Foundation Research Advances Understanding of Health Equity and Outcomes in Fourth-Trimester Care for Women
December 4, 2023 — The Minneapolis Heart Institute Foundation (MHIF), an internationally renowned cardiovascular…
Read More
The device would be the first clinical-grade, diagnostic wrist-worn device for long term Afib monitoring
December 01, 2023
Clinical Smartwatch Finds Success at Identifying Atrial Fibrillation
December 1, 2023 — As the use of wearable technology grows, smartwatches are marketed across the globe to consumers as…
Read More
Mount Sinai Fuster Heart Hospital is one of the world’s top four hospitals in Cardiology/Heart Surgery
December 01, 2023
Transcatheter Valve Replacement Procedures at the Mount Sinai Hospital Win Highest Rating from Society of Thoracic Surgeons
December 1, 2023 — For the third consecutive year, the Cardiac Catheterization Laboratory at The Mount Sinai Hospital…
Read More
Researchers have succeeded in restoring lost brain function in mouse models of stroke using small molecules that in the future could potentially be developed into a stroke recovery therapy.
December 01, 2023
New Study: Lost Brain Function Restored After Stroke
December 1, 2023 — Researchers have succeeded in restoring lost brain function in mouse models of stroke using small…
Read More
Innovative investigational device designed for Left Atrial Appendage Elimination (LAAX) to reduce the risk of stroke in patients with non-valvular atrial fibrillation
November 30, 2023
Johnson & Johnson MedTech Acquires Laminar, Inc.
November 30, 2023 — Johnson & Johnson MedTech1 today announced the completion of the acquisition2 of Laminar, Inc…
Read More
Japan’s PMDA asked for further details on a number of elements included in BioCardia’s CardiAMP preclinical and clinical packages in order to gain approval.
November 30, 2023
BioCardia Shares Update from Japan PMDA Consultation on CardiAMP Autologous Cell Therapy for Ischemic Heart Failure; Foreign Data Expected to be Sufficient for Product Approval
November 30, 2023 —  BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of…
Read More
Data from all three patients in non-randomized cohort treated with DSR 2.0 indicate safe and effective maintenance of euvolemia without the need for loop diuretics, considerable benefit in cardiorenal status and dramatic improvement in diuretic response and loop diuretic requirements up to 11 weeks post DSR treatment
November 30, 2023
Sequana Medical Announces Positive Data from Non-randomized Cohort in US Phase 1/2a MOJAVE Study of DSR 2.0 for Treatment of Heart Failure
November 30, 2023 —  Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure…
Read More
Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced the first patient enrollment in the PEERLESS II study
November 29, 2023
Inari Medical Announces First Patient Enrollment in PEERLESS II Randomized Controlled Trial (RCT)
November 29, 2023 —  Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of…
Read More
Foldax, Inc., a leader in the development of innovative, polymer heart valves, today announced completion of enrollment in the Indian clinical trial of the TRIA polymer surgical mitral heart valve.
November 29, 2023
Foldax Completes Enrollment in India Clinical Trial Evaluating TRIA Polymer Surgical Mitral Heart Valve
November 29, 2023 —  Foldax, Inc., a leader in the development of innovative, polymer heart valves, today announced…
Read More
Study to enroll 15 acute stroke patients across three U.S. sites
November 29, 2023
InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of CGuard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions
November 29, 2023 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention…
Read More
Impella Improves Survival and Heart Recovery
November 28, 2023
First Patient Enrolled in Abiomed’s RECOVER IV Randomized Controlled Trial of Impella as a Therapy for AMI Cardiogenic Shock
November 28, 2023 — Abiomed, part of Johnson & Johnson MedTech[1], announces the first patient in the world has…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now